Weight Loss Peptides
Tirzepatide Injection Pen - 10mg (4 x 2.5mg doses)
Advanced dual GIP/GLP-1 receptor agonist for weight loss and diabetes.
£89
Key Benefits for Research:
- Dual GIP and GLP-1 receptor agonist for comprehensive metabolic pathway study.
- High-purity compound (>99%) ensuring reliable and reproducible research outcomes.
- Convenient and sterile injection pen format for precise dosing and ease of use in laboratory settings.
- Validated for research in areas such as glucose metabolism, insulin sensitivity, and body weight regulation.
- Subjected to rigorous quality control, including HPLC and Mass Spec analysis.
1
This product is for laboratory research use only. Not for human or animal consumption.
Detailed Description
Our Tirzepatide Injection Pen offers a convenient and precise method for administering Tirzepatide in research settings. Known for its potent dual-agonist activity, Tirzepatide is a leading compound for investigating metabolic pathways, glucose regulation, and weight management in preclinical models. This product is intended for laboratory research use only and is not for human or animal diagnostic or therapeutic use.